Vitabrid Japan Inc. (Headquarters: Minato-ku, Tokyo, Representative Director: Hiroshi Otsuka) has launched "Isotretinoin" treatment on its online medical platform, 'Sustaina Online Clinic,' offering a new option for individuals suffering from recurrent or refractory acne. Isotretinoin treatment is a private medical service where a doctor determines the suitability of prescription after assessing the patient's condition, constitution, and potential side effects. Sustaina Online Clinic aims to establish a consultation and treatment system that is easy to access and continue, in collaboration with Omotesando Skin Clinic. A Medical Service Born from Employee "Passion" The background of this service stems from the experiences of staff members who have struggled with acne for many years. These staff members themselves faced daily anxiety and stress, checking their faces in the mirror for new pimples and trying various treatments without improvement. Through their encounter with isotretinoin as a treatment option, a desire arose to 'be a supportive presence for those who suffer similarly,' leading to the launch of this medical field. Sustaina Online Clinic strives to create an environment where patients can undergo treatment with peace of mind, not just by providing medication, but by addressing each patient's anxieties and questions. What is Isotretinoin Treatment? Isotretinoin is an oral medication with 40 years of global usage history (※1) for severe and refractory acne. It directly addresses the cause of acne by shrinking sebaceous glands and reducing sebum secretion by 90-95% (※2), enabling "fundamental treatment." A key feature is its ability to achieve a state where recurrence is less likely even after treatment completion. ※1 Source: Škiljević D. Isotretinoin: 40 years of experience. Galenika Medical Journal. 2022; 4: 84–88. doi:10.5937/galmed2204088s. ※2 Source: Layton A: The use of isotretinoin in acne. Dermato-Endocrinol 2009;1(3):162–169. doi:10.4161/derm.1.3.9